J&J joins Bristol Myers Squibb with $100M commitment to diversity efforts

Nicole DeFeudis

Editor

A day after the Bristol Myers Squibb Foundation launched a $100 million program to diversify clinical trials, Johnson & Johnson says it’s also committing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

J&J joins Bristol Myers Squibb with $100M commitment to diversity efforts

Nicole DeFeudis

Editor

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

CBER's deputy director departs as staff shakeup continues

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

Will CRISPR matter?

FDA approves first drug to treat ultra-rare lipid storage disease

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

J&J joins Bris­tol My­ers Squibb with $100M com­mit­ment to di­ver­si­ty ef­forts

Editor

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

J&J joins Bristol Myers Squibb with $100M commitment to diversity efforts